Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06429787
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-21
Brief Title:
Post Marketing Observational Study on Safety of BALFAXAR vs KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
Sponsor:
Octapharma
Organization:
Octapharma
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Significant Bleeding Risk |
| Vitamin K-Dependent Coagulation Defect |
Keywords: